Birdwatch Note
2024-03-20 12:14:46 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
La ivermectina no cura ni previene el dengue y su uso sin indicación médica puede ser riesgoso para la salud https://chequeado.com/ultimas-noticias/no-la-ivermectina-no-cura-ni-previene-el-dengue-y-su-uso-sin-indicacion-medica-puede-ser-riesgoso-para-la-salud/ https://www.mspbs.gov.py/portal/28679/uso-de-ivermectina-no-esta-indicado-para-prevenir-ni-tratar-dengue.html https://saludconlupa.com/comprueba/es-peligroso-automedicarse-con-ivermectina/
Written by 1D542CC5F7F22B32FE8D0B813F6D4AF0A34C0B05CD75D8A7D840C94D50ED0C85
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1770404023281082543
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1770423737747210486
- noteId - 1770423737747210486
- participantId -
- noteAuthorParticipantId - 1D542CC5F7F22B32FE8D0B813F6D4AF0A34C0B05CD75D8A7D840C94D50ED0C85 Participant Details
- createdAtMillis - 1710936886618
- tweetId - 1770404023281082543
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- La ivermectina no cura ni previene el dengue y su uso sin indicación médica puede ser riesgoso para la salud https://chequeado.com/ultimas-noticias/no-la-ivermectina-no-cura-ni-previene-el-dengue-y-su-uso-sin-indicacion-medica-puede-ser-riesgoso-para-la-salud/ https://www.mspbs.gov.py/portal/28679/uso-de-ivermectina-no-esta-indicado-para-prevenir-ni-tratar-dengue.html https://saludconlupa.com/comprueba/es-peligroso-automedicarse-con-ivermectina/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-03-20 12:14:46 UTC (1710936886618) |
2024-03-20 15:48:05 UTC (1710949685700) |
CURRENTLY_RATED_HELPFUL | 2024-03-21 01:30:52 UTC (1710984652589) |
CURRENTLY_RATED_HELPFUL | 2024-03-20 15:48:05 UTC (1710949685700) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-03-20 18:15:02 -0500 | Rating Details | |
2024-03-20 15:17:30 -0500 | Rating Details | |
2024-03-20 14:52:21 -0500 | Rating Details | |
2024-03-20 14:10:38 -0500 | Rating Details | |
2024-03-20 14:07:41 -0500 | Rating Details | |
2024-03-20 13:19:23 -0500 | Rating Details | |
2024-03-20 13:01:44 -0500 | Rating Details | |
2024-03-20 12:32:32 -0500 | Rating Details | |
2024-03-20 11:57:25 -0500 | Rating Details | |
2024-03-20 11:41:56 -0500 | Rating Details | |
2024-03-20 11:33:32 -0500 | Rating Details | |
2024-03-20 11:14:51 -0500 | Rating Details | |
2024-03-20 11:03:54 -0500 | Rating Details | |
2024-03-20 10:16:21 -0500 | Rating Details | |
2024-03-20 10:04:30 -0500 | Rating Details | |
2024-03-20 09:30:14 -0500 | Rating Details | |
2024-03-20 09:25:49 -0500 | Rating Details | |
2024-03-20 09:25:08 -0500 | Rating Details | |
2024-03-20 09:11:06 -0500 | Rating Details | |
2024-03-20 08:54:58 -0500 | Rating Details | |
2024-03-20 08:51:13 -0500 | Rating Details | |
2024-03-20 08:50:16 -0500 | Rating Details | |
2024-03-20 08:49:31 -0500 | Rating Details | |
2024-03-20 08:48:01 -0500 | Rating Details | |
2024-03-20 08:45:31 -0500 | Rating Details | |
2024-03-20 08:40:42 -0500 | Rating Details | |
2024-03-20 08:40:36 -0500 | Rating Details | |
2024-03-20 08:34:28 -0500 | Rating Details | |
2024-03-20 08:32:53 -0500 | Rating Details | |
2024-03-20 08:22:59 -0500 | Rating Details | |
2024-03-20 08:15:25 -0500 | Rating Details | |
2024-03-20 08:07:21 -0500 | Rating Details | |
2024-03-20 08:04:31 -0500 | Rating Details | |
2024-03-20 08:04:23 -0500 | Rating Details | |
2024-03-20 08:04:17 -0500 | Rating Details | |
2024-03-20 07:51:28 -0500 | Rating Details | |
2024-03-20 07:38:24 -0500 | Rating Details | |
2024-03-21 10:30:27 -0500 | Rating Details | |
2024-03-21 06:19:44 -0500 | Rating Details | |
2024-03-21 04:18:40 -0500 | Rating Details | |
2024-03-21 00:47:10 -0500 | Rating Details | |
2024-03-20 23:00:02 -0500 | Rating Details | |
2024-03-20 22:46:48 -0500 | Rating Details | |
2024-03-20 20:21:29 -0500 | Rating Details | |
2024-03-20 19:38:59 -0500 | Rating Details | |
2024-03-21 14:30:48 -0500 | Rating Details | |
2024-03-21 13:34:37 -0500 | Rating Details | |
2024-03-21 12:13:21 -0500 | Rating Details | |
2024-03-21 08:22:54 -0500 | Rating Details | |
2024-03-21 06:20:32 -0500 | Rating Details | |
2024-03-21 06:14:15 -0500 | Rating Details | |
2024-03-21 06:13:17 -0500 | Rating Details | |
2024-03-21 05:59:36 -0500 | Rating Details | |
2024-03-21 05:44:27 -0500 | Rating Details | |
2024-03-21 05:12:59 -0500 | Rating Details | |
2024-03-20 22:42:28 -0500 | Rating Details | |
2024-03-20 21:46:19 -0500 | Rating Details | |
2024-03-20 21:27:27 -0500 | Rating Details | |
2024-03-20 21:10:37 -0500 | Rating Details | |
2024-03-20 20:22:29 -0500 | Rating Details | |
2024-03-20 20:18:49 -0500 | Rating Details | |
2024-03-20 18:54:54 -0500 | Rating Details | |
2024-03-20 18:45:43 -0500 | Rating Details | |
2024-03-20 18:20:48 -0500 | Rating Details | |
2024-03-20 17:53:33 -0500 | Rating Details | |
2024-03-20 17:05:12 -0500 | Rating Details | |
2024-03-20 17:00:58 -0500 | Rating Details | |
2024-03-20 16:47:49 -0500 | Rating Details | |
2024-03-20 16:39:41 -0500 | Rating Details | |
2024-03-20 15:49:17 -0500 | Rating Details | |
2024-03-20 14:01:58 -0500 | Rating Details | |
2024-03-20 13:26:53 -0500 | Rating Details | |
2024-03-20 12:25:07 -0500 | Rating Details | |
2024-03-20 11:55:21 -0500 | Rating Details | |
2024-03-20 11:54:30 -0500 | Rating Details | |
2024-03-20 11:47:03 -0500 | Rating Details | |
2024-03-20 11:36:48 -0500 | Rating Details | |
2024-03-20 11:31:43 -0500 | Rating Details | |
2024-03-20 11:06:36 -0500 | Rating Details | |
2024-03-20 11:02:20 -0500 | Rating Details | |
2024-03-20 10:03:01 -0500 | Rating Details | |
2024-03-20 10:02:15 -0500 | Rating Details | |
2024-03-20 09:43:15 -0500 | Rating Details | |
2024-03-20 09:31:16 -0500 | Rating Details | |
2024-03-20 09:30:34 -0500 | Rating Details | |
2024-03-20 09:27:57 -0500 | Rating Details | |
2024-03-20 08:53:38 -0500 | Rating Details | |
2024-03-20 08:51:08 -0500 | Rating Details | |
2024-03-20 08:43:54 -0500 | Rating Details | |
2024-03-20 08:39:00 -0500 | Rating Details | |
2024-03-20 08:35:41 -0500 | Rating Details | |
2024-03-20 08:34:18 -0500 | Rating Details | |
2024-03-20 08:32:58 -0500 | Rating Details | |
2024-03-20 08:17:10 -0500 | Rating Details | |
2024-03-20 08:07:06 -0500 | Rating Details | |
2024-03-20 08:05:26 -0500 | Rating Details | |
2024-03-20 07:59:07 -0500 | Rating Details | |
2024-03-20 07:58:34 -0500 | Rating Details | |
2024-03-20 07:31:06 -0500 | Rating Details | |
2024-03-20 07:21:28 -0500 | Rating Details | |
2024-03-23 04:15:00 -0500 | Rating Details | |
2024-03-21 22:34:05 -0500 | Rating Details | |
2024-03-21 07:17:23 -0500 | Rating Details | |
2024-03-21 03:18:52 -0500 | Rating Details | |
2024-03-21 02:40:25 -0500 | Rating Details | |
2024-03-20 17:24:10 -0500 | Rating Details | |
2024-03-20 17:23:47 -0500 | Rating Details | |
2024-03-20 17:00:04 -0500 | Rating Details | |
2024-03-20 16:50:58 -0500 | Rating Details | |
2024-03-20 16:28:04 -0500 | Rating Details | |
2024-03-20 16:10:44 -0500 | Rating Details | |
2024-03-20 16:09:06 -0500 | Rating Details | |
2024-03-20 15:49:14 -0500 | Rating Details | |
2024-03-20 15:12:13 -0500 | Rating Details | |
2024-03-20 15:10:48 -0500 | Rating Details | |
2024-03-20 15:05:50 -0500 | Rating Details | |
2024-03-20 12:16:30 -0500 | Rating Details | |
2024-03-20 11:31:17 -0500 | Rating Details | |
2024-03-20 11:12:07 -0500 | Rating Details | |
2024-03-20 11:11:40 -0500 | Rating Details | |
2024-03-20 11:00:00 -0500 | Rating Details | |
2024-03-20 10:17:46 -0500 | Rating Details | |
2024-03-20 10:05:02 -0500 | Rating Details | |
2024-03-20 09:55:48 -0500 | Rating Details | |
2024-03-20 09:55:16 -0500 | Rating Details | |
2024-03-20 09:08:30 -0500 | Rating Details | |
2024-03-20 08:49:16 -0500 | Rating Details | |
2024-03-20 08:46:01 -0500 | Rating Details | |
2024-03-20 08:38:15 -0500 | Rating Details | |
2024-03-20 08:34:03 -0500 | Rating Details | |
2024-03-20 08:30:04 -0500 | Rating Details | |
2024-03-20 08:30:04 -0500 | Rating Details | |
2024-03-20 08:29:53 -0500 | Rating Details | |
2024-03-20 08:24:48 -0500 | Rating Details | |
2024-03-20 08:03:10 -0500 | Rating Details | |
2024-03-20 07:49:33 -0500 | Rating Details | |
2024-03-20 07:16:10 -0500 | Rating Details | |
2024-03-23 02:06:17 -0500 | Rating Details |